PL2809801T3 - Nieinwazyjna diagnoza raka - Google Patents

Nieinwazyjna diagnoza raka

Info

Publication number
PL2809801T3
PL2809801T3 PL13701662T PL13701662T PL2809801T3 PL 2809801 T3 PL2809801 T3 PL 2809801T3 PL 13701662 T PL13701662 T PL 13701662T PL 13701662 T PL13701662 T PL 13701662T PL 2809801 T3 PL2809801 T3 PL 2809801T3
Authority
PL
Poland
Prior art keywords
cancer diagnosis
invasive cancer
invasive
diagnosis
cancer
Prior art date
Application number
PL13701662T
Other languages
English (en)
Inventor
Robert Zeillinger
Original Assignee
SPEISER, Paul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SPEISER, Paul filed Critical SPEISER, Paul
Publication of PL2809801T3 publication Critical patent/PL2809801T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL13701662T 2012-01-31 2013-01-31 Nieinwazyjna diagnoza raka PL2809801T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12153340 2012-01-31
PCT/EP2013/051899 WO2013113816A1 (en) 2012-01-31 2013-01-31 Non-invasive cancer diagnosis
EP13701662.2A EP2809801B1 (en) 2012-01-31 2013-01-31 Non-invasive cancer diagnosis

Publications (1)

Publication Number Publication Date
PL2809801T3 true PL2809801T3 (pl) 2018-12-31

Family

ID=47624102

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13701662T PL2809801T3 (pl) 2012-01-31 2013-01-31 Nieinwazyjna diagnoza raka

Country Status (11)

Country Link
US (1) US9493839B2 (pl)
EP (1) EP2809801B1 (pl)
CA (1) CA2863144A1 (pl)
DK (1) DK2809801T3 (pl)
ES (1) ES2691404T3 (pl)
HR (1) HRP20181726T1 (pl)
PL (1) PL2809801T3 (pl)
PT (1) PT2809801T (pl)
SI (1) SI2809801T1 (pl)
TR (1) TR201815847T4 (pl)
WO (1) WO2013113816A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012103266A2 (en) 2011-01-25 2012-08-02 Nvision Medical Corporation Systems and methods for maintaining a narrow body lumen
PL3246416T3 (pl) 2011-04-15 2024-09-30 The Johns Hopkins University Bezpieczny system sekwencjonowania
CN109457030B (zh) 2012-10-29 2022-02-18 约翰·霍普金斯大学 卵巢和子宫内膜癌的帕帕尼科拉乌测试
US10639016B2 (en) 2013-02-01 2020-05-05 Boston Scientific Scimed, Inc. Methods and devices for Fallopian tube diagnostics
US11179143B2 (en) 2013-02-01 2021-11-23 Boston Scientific Scimed, Inc. Systems, methods, and devices for fallopian tube diagnostics
US11291434B2 (en) 2013-02-01 2022-04-05 Nvision Medical Corporation Systems, methods, and devices for fallopian tube diagnostics
CN110946544A (zh) 2013-02-01 2020-04-03 波士顿科学医学有限公司 输卵管诊断装置及方法
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
US20170327898A1 (en) * 2016-05-16 2017-11-16 The Johns Hopkins University Ovarian carcinoma detection and prophylaxis
CN107419001A (zh) * 2016-05-23 2017-12-01 益善生物技术股份有限公司 Brca1、pten基因异常检测试剂盒及检测方法
WO2017220782A1 (en) * 2016-06-24 2017-12-28 Molecular Health Gmbh Screening method for endometrial cancer
EP3665308A1 (en) * 2017-08-07 2020-06-17 The Johns Hopkins University Methods and materials for assessing and treating cancer
AU2018354407A1 (en) 2017-10-27 2020-03-12 Boston Scientific Scimed, Inc. Cell collection and preparation devices and methods
US12551203B2 (en) 2018-12-28 2026-02-17 Cellapax Corporation Catheter with vessel lining for cell collection and methods for using same
CN111440865B (zh) * 2019-01-17 2023-08-01 中山大学附属第六医院 Fat3基因甲基化检测试剂在制备结直肠癌预后诊断试剂中的应用
BR112022015909A2 (pt) 2020-02-14 2022-10-04 Univ Johns Hopkins Métodos e materiais para avaliação de ácidos nucleicos
US20220036974A1 (en) * 2020-07-28 2022-02-03 University Of Iowa Research Foundation Pooled testing methods using compressed sensing for increasing the throughput and reliability of tests for the detection of defective units in a population
CN115418340A (zh) * 2022-06-09 2022-12-02 中南大学湘雅医院 人宫腔灌洗液来源的子宫内膜类器官的培养方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
US6221623B1 (en) 1997-11-10 2001-04-24 The Regents Of The University Of California Biochemical methods for detecting cervical dysplasia and cancer
JP2000166557A (ja) * 1998-09-29 2000-06-20 Sumitomo Electric Ind Ltd 染色体異常の検出による子宮内膜癌の診断方法
AU4592601A (en) 2000-03-21 2001-10-03 Millennium Predictive Medicine Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
US7279294B2 (en) 2000-04-03 2007-10-09 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services, Nih Tumor markers in ovarian cancer
WO2002046765A2 (en) * 2000-11-08 2002-06-13 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
RU2448708C3 (ru) * 2006-05-18 2017-09-28 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Противоопухолевое средство против рака щитовидной железы
US20120082978A1 (en) * 2006-09-15 2012-04-05 Linda Pilarski Cell Analysis On Microfluidic Chips
WO2009006543A1 (en) * 2007-07-02 2009-01-08 Euclid Diagnostics Llc Methods for evaluating the methylation status of a polynucleotide

Also Published As

Publication number Publication date
EP2809801B1 (en) 2018-07-25
TR201815847T4 (tr) 2018-11-21
EP2809801A1 (en) 2014-12-10
PT2809801T (pt) 2018-11-20
DK2809801T3 (en) 2018-11-12
ES2691404T3 (es) 2018-11-27
CA2863144A1 (en) 2013-08-08
HRP20181726T1 (hr) 2018-12-28
SI2809801T1 (sl) 2018-12-31
WO2013113816A1 (en) 2013-08-08
US20140011199A1 (en) 2014-01-09
US9493839B2 (en) 2016-11-15

Similar Documents

Publication Publication Date Title
IL267242B (en) Cancer treatment
SI2809801T1 (sl) Neinvazivna diagnostika raka
GB2509193B (en) Dual-Modality Mammography
EP2878272A4 (en) ULTRASOUND ENDOSCOPE
EP2815691A4 (en) ENDOSCOPE
EP2830416A4 (en) FABRIC RETRACTOR
EP2692278A4 (en) Borescope
EP2820999A4 (en) ENDOSCOPE
EP2891448A4 (en) ENDOSCOPE
EP2837320A4 (en) Borescope
EP2835093A4 (en) ENDOSCOPE
GB201213304D0 (en) Ultrasonic imaging
EP2868252A4 (en) Borescope
GB2500893B (en) Spirometer
EP2856924A4 (en) Borescope
EP2679167A4 (en) sonographer
EP2865318A4 (en) ENDOSCOPE
SG11201502499UA (en) Cancer diagnosis device
IL234658B (en) Pharmaceutical diagnostic
GB201205189D0 (en) Novel medical use
DK2872176T3 (en) Cancer treatment
GB201215502D0 (en) Medical use
GB201222563D0 (en) Cancer treatment
IL229109B (en) Cancer diagnosis
GB201219207D0 (en) Non-invasive monitor